Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves a new type of schizophrenia drug
FDA approves 1st new drug to treat schizophrenia in more than 30 years
This drug takes the first new approach to schizophrenia treatment in decades," Farchione continued. "This approval offers a new alternative to the antipsychotic medications peo
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna Therapeutics.
FDA issues recall notices for two brands of pet food
FDA issues recall notices for two brands of pet food over salmonella and listeria contamination
Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them
These 2 brands of pet food may be contaminated with salmonella and listeria, FDA says
The U.S. FDA issued warnings for ANSWERS Pet Food and Darwin's Natural Pet Products as they contain Salmonella and Listeria. Biggest risk is passing it on to humans.
Publisher’s Platform: Will the FDA use its recall authority to mandate a pet food recall due to Salmonella and Listeria?
The FDA has issued a similar warning for some Answers brand pet food. The manufacturer, Lystn LLC, has not issued a recall,
FDA Lifts Clinical Hold On BMF-219
US FDA lifts clinical hold on Biomea's diabetes trials
Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials
We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.
Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials
Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,
pulmonologyadvisor
6d
FDA Alert: Pulmonology Drug Approvals and Recalls, Medical Device Updates
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
dermatologyadvisor
1d
FDA Approves Self-Administration of Influenza Vaccine FluMist
The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Promotes watch collection
World's oldest cheese found
Producing doc on Diddy
Boxes to distribute Narcan
50/50 ball ownership suit
Ending password-sharing
Urgent safety alert for 737s
US sanctions crypto network
Targeted Black residents?
Stadiums to serve as shelters
Chinese submarine sank
Kotb leaving 'Today'
More executives leave
On Secret Service failures
NC board removes 747K
NIH finds misconduct
WI duplicate ballot flap
Military recruiting rebounds
To withdraw sickle cell drug
Settles defamation lawsuit
Capital goods orders up
Arrives in Luxembourg
Weekly jobless claims fall
Rose announces retirement
US economy grew
US suicides steady, high
Jan. 6 report delayed
RU hits Ukraine's power grid
Feedback